BioCentury
ARTICLE | Clinical News

Axonyx reports Phase I data

March 28, 2000 8:00 AM UTC

AXYX said that its Phenserine aceytycholinesterase inhibitor to treat Alzheimer's disease showed significant inhibition of acetylcholinesterase. ...